Advisor Partners’s DexCom DXCM Stock Holding History

Advisor Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$478K	Buy	6,414 +698	+12%	+$63.7K	0.03%	494
2022 Q1	$731K	Buy	5,716 +568	+11%	+$62.1K	0.05%	399
2021 Q4	$692K	Buy	5,148 +2,540	+97%	+$365K	0.04%	419
2021 Q3	$357K	Buy	2,608 +500	+24%	+$63.1K	0.02%	581
2021 Q2	$225K	Buy	+2,108	New	+$202K	0.01%	754
2020 Q4	–	Sell	-3,172	Closed	-$327K	–	760
2020 Q3	$327K	Buy	3,172 +364	+13%	+$38K	0.03%	502
2020 Q2	$285K	Buy	+2,808	New	+$251K	0.03%	534

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisor Partners's DXCM Position: Q2 2022 in Review

Advisor Partners increased its DexCom (DXCM) stake by 12% in Q2 2022, buying an estimated $63.7K and bringing the position to 6,414 shares worth $478K. The position accounts for 0.03% of the portfolio, ranked #494.

Advisor Partners first reported a position in DXCM in Q2 2020 and has held it in 7 quarters since. The position peaked at $731K in Q1 2022. 798 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

Advisor Partners held 6,414 shares of DexCom worth $478K as of Q2 2022.
Advisor Partners bought 698 DexCom shares in Q2 2022, an estimated $63.7K.
DexCom made up 0.03% of Advisor Partners's portfolio in Q2 2022, its #494 holding.
Advisor Partners first reported a position in DexCom in Q2 2020 and has held it in 7 quarters since.
Advisor Partners's DexCom position peaked at $731K in Q1 2022.
798 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.